Israel Institute for Biological Research

Israel Institute for Biological Research (IIBR) is an Israeli research and development laboratory [1] It is under the jurisdiction of the Prime Minister's Office[2] that works in close cooperation with Israeli government agencies. IIBR has many public projects on which it works with international research organizations (governmental and non-governmental) and universities. It has approximately 350 employees, 150 of whom are scientists. Its research findings are often published in national and international scientific publications.[1] It is widely believed to be involved in the manufacturing of biological and chemical weapons.[3] The IIBR is currently developing a COVID-19 vaccine Brilife.[4]

  1. ^ a b IIBR website
  2. ^ Cite error: The named reference Ostrovsky was invoked but never defined (see the help page).
  3. ^ Ginsburg, Mitch. "'Should there be a need': The inside story of Israel's chemical and biological arsenal". www.timesofisrael.com. Retrieved 2020-05-07.
  4. ^ "Israel names its vaccine candidate: Brilife - The Jerusalem Post". Archived from the original on 2020-10-19.